CCR 20th anniversary commentary: Stayin' alive-antiapoptotic proteins and breast cancer

Research output: Contribution to journalReview articlepeer-review

Abstract

The control of cell death involves a complex interaction of multiple proteins. In a study published in the January 1, 2000, issue of Clinical Cancer Research, Tanaka and colleagues demonstrated that one of the proapoptotic proteins, survivin, was frequently expressed in breast cancer. In the subsequent years, effectors of apoptosis have translated into important prognostic indicators and potential therapeutic targets. -

Original languageEnglish (US)
Pages (from-to)665-666
Number of pages2
JournalClinical Cancer Research
Volume21
Issue number4
DOIs
StatePublished - Feb 15 2015

Fingerprint Dive into the research topics of 'CCR 20<sup>th</sup> anniversary commentary: Stayin' alive-antiapoptotic proteins and breast cancer'. Together they form a unique fingerprint.

Cite this